1. Corporate Officers - S
2. Stenhouse Mark

Insider Trading History of Stenhouse Mark

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Stenhouse Mark since 2019. This trader's CIK number is 1734751. At the time of last reporting, Stenhouse Mark was the Chief Operating Officer of Prometheus Biosciences, Inc.. (stock ticker symbol RXDX). Also see all insider trading activities at Prometheus Biosciences, Inc..

Note that in the past Stenhouse Mark also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Exact Sciences Corp (EXAS) by Stenhouse Mark

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2020	EXAS	0	$0	12,999	$761,695	28,262	$0
2019	EXAS	0	$0	11,192	$1,035,696	25,000	$0

Yearly summary of insider trading at Prometheus Biosciences, Inc. (RXDX) by Stenhouse Mark

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2021	RXDX	14,000	$266,000	0	$0	0	$0

Insider trading activities at 2 companies by Stenhouse Mark:

1. Exact Sciences Corp (EXAS)

2. Prometheus Biosciences, Inc. (RXDX)

Table 1. Insider trading of Exact Sciences Corp (EXAS) by Stenhouse Mark

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2020-04-03	EXAS	Sale	11,948	56.69	677,332
2020-04-02	EXAS	Option Ex	25,000	.00	0
2020-02-27	EXAS	Sale	1,051	80.27	84,363
2020-02-26	EXAS	Option Ex	3,262	.00	0
2019-04-03	EXAS	Sale	11,192	92.54	1,035,696
2019-04-02	EXAS	Option Ex	25,000	.00	0

Table 2. Insider trading of Prometheus Biosciences, Inc. (RXDX) by Stenhouse Mark

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2021-03-16	RXDX	Buy	14,000	19.00	266,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Stenhouse Mark (Chief Operating Officer of Prometheus Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month